XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net revenues $ 696,496 $ 983,162 $ 2,213,317 $ 3,044,838
Cost of sales 375,075 507,684 1,360,602 1,628,268
Gross Profit 321,421 475,478 852,715 1,416,570
Operating expenses:        
Research and development 177,502 140,192 439,832 399,894
Selling, general and administrative 249,306 242,533 883,716 855,656
Total operating expenses 426,808 382,725 1,323,548 1,255,550
Income (loss) from operations (105,387) 92,753 (470,833) 161,020
Other income (expense):        
Interest income 5,663 3,676 20,256 4,670
Interest and finance expenses (5,291) (2,658) (14,804) (10,542)
Total other income (expense) 372 1,018 5,452 (5,872)
Income (loss) before provision for income taxes (105,015) 93,771 (465,381) 155,148
Total provision (benefit) for income taxes 0 0 0 0
Net income (loss) $ (105,015) $ 93,771 $ (465,381) $ 155,148
Basic and diluted per common share: (in dollars per share) $ (0) $ 0 $ (0.01) $ 0
Weighted average shares of common stock outstanding - basic and diluted (in shares) 67,588,492 67,588,492 67,588,492 67,588,492